Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

a Phase 1/2 study evaluating rese-cel in patients with multiple sclerosis (MS). In addition, the FDA has granted Fast Track Designation to rese-cel for the treatment of relapsing and progressive ...

About ALS Amyotrophic lateral sclerosis (ALS) is the most prevalent adult-onset progressive motor neuron disease ... industry partners and research collaborators to evaluate multiple investigational ...

Company plans to meet with the FDA to align on registrational trial designs in 1H25 based on emerging clinical profile of resecabtagene autoleucel (rese-cel, formerly referred to as CABA-201) and ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has revealed significant progress in its pipeline and operations, ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...

A recent study by UC San Francisco has uncovered that menopause has a negative influence on several prodromal symptoms of Multiple Sclerosis, thus catalysing its progression. Multiple Sclerosis ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin ...

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

Get Instant Summarized Text (Gist) An experimental drug, LL-341070, has been shown to accelerate myelin repair in the brain, improving vision in mice with severe myelin damage. This drug enhances ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...